All patientsn=182 Males n=159 (87.4%) Femalesn=23 (12.6%) p value
During ICCU
ß-blockers 169 (92.9) 147 (92.5) 22 (95.7) 0.578
ACEi - ARB 165 (90.7) 147 (92.5) 18 (78.3) 0.029
Calcium channel blockers 4 (2.2) 3 (1.9) 1 (4.3) 0.420*
Diuretics 106 (58.2) 91 (57.2) 15 (65.2) 0.468
ASA 182 (100) 159 (100) 23 (100) 1*
Clopidogrel 175 (96.2) 154 (96.9) 21 (91.3) 0.196
IIbIIIa GP inhibitors 159 (87.4) 140 (88.1) 19 (82.6) 0.463
Statin 177 (97.3) 156 (98.1) 21 (91.3) 0.121*
At discharge  All patients Men Women  
n=178 n=156 (87.6%) n=22 (12.4%)
ß-blockers 162 (91.0) 140 (89.7) 22 (100) 0.115
ACEi - ARB 158 (88.8) 141 (90.4) 17 (77.3) 0.068
Ca channel blockers 3 (1.7) 2 (1.3) 1 (4.5) 0.328*
Diuretics 68 (38.2) 59 (37.8) 9 (40.9) 0.78
ASA 177 (99.4) 155 (99.4) 22 (100) 1*
Clopidogrel 154 (86.5) 136 (87.2) 18 (81.8) 0.491
Statins 173 (97.2) 152 (97.4) 21 (95.5) 0.487*

All values are frequancies (%)
*Fisher’s exact test
ARB: angiotensin receptor blockers, IIbIIIa GP inhibitors: IIbIIIa glycoprotein inhibitors
Table 5 Medications